Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

BACKGROUND: A relatively high proportion of patients diagnosed with primary CNS lymphoma will experience recurrent disease, yet therapy options are limited in salvage therapy. This is the first study to evaluate a bendamustine-based combination regimen for the treatment of relapsed/refractory PCNSL...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Therasa, Choi, He Yun, Lee, Hyun-Seo, Jung, Sung-Hoon, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Lee, Je-Jung, Yoo, Hee-Doo, Yang, Deok-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038347/
https://www.ncbi.nlm.nih.gov/pubmed/29986691
http://dx.doi.org/10.1186/s12885-018-4632-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038347/
https://www.ncbi.nlm.nih.gov/pubmed/29986691
http://dx.doi.org/10.1186/s12885-018-4632-y

Ejemplares similares